Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control [1]

C. L. Harper-Wynne, K. Sumpter, C. Ryan, K. Priest, A. Norton, P. Ross, H. E.R. Ford, P. Johnson, M. E.R. O'Brien

Research output: Contribution to journalLetterpeer-review

11 Scopus citations
Original languageEnglish (US)
Pages (from-to)289-290
Number of pages2
JournalLung Cancer
Volume47
Issue number2
DOIs
StatePublished - Feb 2005
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this